Allergic rhinitis. Allergic rhinitis, unspecified
Conditions
Interventions
Intervention 1: The intervention group 2 are prescribed Silybum marianum capsule 140mg two times daily and standard medication. Intervention 2: The control group are prescribed standard medication onl
Treatment - Drugs
The intervention group 2 are prescribed Silybum marianum capsule 140mg two times daily and standard medication.
The control group are prescribed standard medication only.
The intervention group 1 are prescribed Panax ginseng capsule 500mg two times daily and standard medication.
Sponsors
Vice Chansellor for Research, Shahrekord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 18-55 year old paitients with allergic rhinitis for two last years. Exclusion criteria: Paitients with cardiac diseasis, asthma, high blood pressure, diabet melitus. Pregnancy and lactation. Paitients who use asprin, varfarin, anti hypertensive drugs and anti phsycotic drugs.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sneezing. Timepoint: first day,seventh day,forteenth day,thirtieth day. Method of measurement: clinical evaluation.;Nasal discharge. Timepoint: first day,seventh day,forteenth day,thirtieth day. Method of measurement: clinical evaluation.;Nasal itching. Timepoint: first day,seventh day,forteenth day,thirtieth day. Method of measurement: clinical evaluation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nasal obstraction or congestion. Timepoint: first day,seventh day, fourteenth day, thirtieth day. Method of measurement: clinical evaluation.;Occular itching. Timepoint: first day,seventh day, fourteenth day, thirtieth day. Method of measurement: clinical evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSoroush Amani MD
Shahrekord University of Medical Sciences
Outcome results
None listed